Yuki Miyamoto

26PUBLICATIONS
13CO-AUTHORS
Nanoscale characterisationNeurology and neuromuscular diseasesBiomaterialsCheminformatics and quantitative structure-activity relationshipsNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 15, 2026
Modeling NDD-Associated NLGN2 Depletion Using CRISPR/Cas13 Reveals Exaggerated Process Elongation Mediated by the CCDC88A-G Protein-ELMO Axis.

|Aug 13, 2026
Signaling Through Girdin Underlies Excessive Cell Morphogenesis Resulting from Depletion of Neurodevelopmental Disorder-Related Neurexin-2.

|Jun 26, 2026
Hesperetin Rescues Amyloid Beta-Induced Defects in Neurite Outgrowth Under In Vitro Mild Cognitive Impairment-like Cellular Conditions.

|May 29, 2026
Structural basis for auto-inhibition of the Rac1/Cdc42 guanine nucleotide exchange factor DOCK6 by oligomer formation.

|May 04, 2026
The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells.

|Feb 27, 2026
Hesperetin, Acting Through Inhibition of c-Jun Signaling, Mitigates Hypomyelinating Disease-Associated Stop-Loss Claudin-11-Induced Defective Morphogenesis in Oligodendroglial FBD-102b Cells.

Yuki Miyamoto, Takeru Omata, Yuta Muraki

Pageof 5

Frequent Collaborators

26 joint publications

Junji Yamauchi

8 joint publications

Katsuya Ohbuchi

7 joint publications

Hideji Yako

5 joint publications

Tomohiro Torii